Last Close
Apr 06  •  04:00PM ET
19.32
Dollar change
-0.52
Percentage change
-2.62
%
IndexRUT P/E- EPS (ttm)-2.81 Insider Own67.07% Shs Outstand58.35M Perf Week-0.72%
Market Cap1.13B Forward P/E- EPS next Y-2.20 Insider Trans-0.15% Shs Float19.22M Perf Month-18.48%
Enterprise Value883.01M PEG- EPS next Q-0.59 Inst Own42.55% Short Float14.57% Perf Quarter-20.79%
Income-147.18M P/S13.47 EPS this Y54.33% Inst Trans24.33% Short Ratio7.95 Perf Half Y-20.69%
Sales83.72M P/B3.91 EPS next Y6.30% ROA-59.05% Short Interest2.80M Perf YTD-27.15%
Book/sh4.94 P/C3.87 EPS next 5Y29.86% ROE-97.73% 52W High30.00 -35.60% Perf Year-16.97%
Cash/sh4.99 P/FCF- EPS past 3/5Y-18.44% - ROIC-44.00% 52W Low13.25 45.81% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y179.99% - Gross Margin48.75% Volatility7.39% 8.80% Perf 5Y-
Dividend TTM- EV/Sales10.55 EPS Y/Y TTM-47.91% Oper. Margin-171.53% ATR (14)1.63 Perf 10Y-
Dividend Ex-Date- Quick Ratio7.16 Sales Y/Y TTM59.06% Profit Margin-175.80% RSI (14)40.76 Recom1.29
Dividend Gr. 3/5Y- - Current Ratio7.32 EPS Q/Q-26.51% SMA20-3.90% Beta1.09 Target Price28.71
Payout- Debt/Eq0.16 Sales Q/Q62.70% SMA50-16.72% Rel Volume0.86 Prev Close19.84
Employees330 LT Debt/Eq0.16 EarningsMar 17 AMC SMA200-12.65% Avg Volume352.16K Price19.32
IPOMar 06, 2025 Option/ShortNo / Yes EPS/Sales Surpr.-2.33% 7.35% Trades Volume301,989 Change-2.62%
Date Action Analyst Rating Change Price Target Change
Nov-18-25Initiated BTIG Research Buy $32
Mar-31-25Initiated Wolfe Research Outperform $29
Mar-31-25Initiated Wells Fargo Overweight $28
Mar-31-25Initiated Stifel Buy $28
Mar-31-25Initiated Piper Sandler Overweight $27
Mar-31-25Initiated Goldman Neutral $24
Mar-31-25Initiated BofA Securities Buy $30
Mar-25-26 08:00AM
Mar-18-26 08:30AM
Mar-17-26 11:01PM
04:01PM
Mar-16-26 09:16AM
06:00AM Loading…
Mar-03-26 06:00AM
Jan-14-26 11:05AM
Jan-13-26 06:00AM
Dec-30-25 06:00AM
Dec-12-25 12:00AM
Dec-11-25 04:01PM
05:36AM
04:29AM
Dec-10-25 07:15AM
Dec-03-25 08:00AM
10:11PM Loading…
Dec-02-25 10:11PM
Dec-01-25 07:16AM
07:01AM
Nov-10-25 09:52AM
Nov-04-25 08:00AM
Oct-28-25 08:00AM
Oct-07-25 08:00AM
Sep-25-25 08:00AM
Sep-17-25 08:00AM
Sep-12-25 03:04AM
Sep-11-25 04:01PM
04:55AM
04:13AM
Aug-28-25 08:00AM
Aug-04-25 08:05AM
08:31AM Loading…
Jul-31-25 08:31AM
Jul-29-25 03:20PM
Jul-17-25 08:00AM
Jul-16-25 09:28PM
03:05AM
Jul-15-25 04:01PM
Jul-01-25 08:00AM
Jun-23-25 08:00AM
Jun-05-25 08:00AM
May-13-25 08:00AM
Apr-30-25 08:00AM
Apr-29-25 08:00AM
Apr-23-25 08:00AM
Apr-14-25 04:01PM
Apr-02-25 04:05PM
Mar-14-25 04:05PM
Mar-07-25 05:30PM
Mar-05-25 11:03PM
Feb-26-25 08:00AM
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Traci S. Umberger in 2014 and is headquartered in Kirkland, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN RAYMOND WDirectorMar 26 '26Buy19.9810,000199,80050,903Mar 30 06:06 PM
Webster Brian DanielSee RemarksMar 17 '26Sale20.2715,000304,124364,786Mar 19 04:10 PM
Webster Brian DanielOfficerMar 17 '26Proposed Sale20.2715,000304,123Mar 17 06:17 PM
Webster Brian DanielSee RemarksFeb 17 '26Sale25.6015,000384,020379,786Feb 19 04:35 PM
Webster Brian DanielOfficerFeb 17 '26Proposed Sale25.6015,000384,020Feb 17 04:05 PM
Webster Brian DanielSee RemarksJan 15 '26Sale22.8015,000342,024394,786Jan 20 06:00 AM
Webster Brian DanielOfficerJan 15 '26Proposed Sale22.8015,000342,024Jan 15 04:20 PM
Umberger Traci SSee RemarksDec 29 '25Sale26.6910,500280,201136,633Dec 31 04:16 PM
Webster Brian DanielSee RemarksDec 29 '25Sale26.5915,000398,847409,786Dec 31 04:14 PM
Umberger Traci SOfficerDec 29 '25Proposed Sale26.6910,500280,201Dec 29 04:36 PM
Webster Brian DanielOfficerDec 29 '25Proposed Sale26.5915,000398,847Dec 29 04:35 PM